Misdiagnosis of diabetic foot ulcer in patients with undiagnosed skin malignancies

Int Wound J. 2022 May;19(4):871-887. doi: 10.1111/iwj.13688. Epub 2021 Oct 29.

Abstract

A growing number of studies report dermal malignancies mimicking diabetic foot ulcers (DFUs). We reviewed clinical cases reporting malignant tumours misdiagnosed to be DFU aiming to identify factors contributing to misdiagnosis. We systematically searched in PubMed for clinical cases reporting on misdiagnosis of DFU in patients with cancer. A chi-square analysis was conducted to show the link between the incidence of initial DFU misdiagnosis and patient age, gender and wound duration. Lesions misdiagnosed to be DFU were subsequently diagnosed as melanoma (68% of the cases), Kaposi's sarcoma (14%), squamous cell carcinoma (11%), mantle cell lymphoma, and diffuse B-cell lymphoma (both by 4%). Older age (≥65 years) was associated with a significantly increased risk of malignancy masked as DFU (OR: 2.452; 95% CI: 1.132 to 5.312; P value = .019). The risk of such suspicion in older patients (age ≥ 65 years) was 145% higher than in younger patients (age < 65 years). Clinicians should maintain a high level of awareness towards potentially malignant foot lesions in elderly patients with diabetes (age ≥ 65).

Keywords: diabetic foot ulcer; malignancy; melanoma; misdiagnosis; skin cancer.

MeSH terms

  • Adult
  • Aged
  • Diabetes Mellitus*
  • Diabetic Foot* / complications
  • Diagnostic Errors
  • Foot
  • Foot Ulcer*
  • Humans
  • Incidence
  • Skin Neoplasms* / complications
  • Skin Neoplasms* / diagnosis